ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 0137 • ACR Convergence 2023

    Incidence of and Risk Factors for Myelodysplastic Syndromes in Patients with Rheumatologic Diseases

    YoungEun Kim1, Hansun Song1, Wook Jang Seo2, Jinseok Kim3, Soo Min Ahn1, Seokchan Hong4, Ji-Seon Oh5, Chang-Keun Lee6, Bin Yoo6 and Yong-Gil Kim1, 1Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, 2Department of Rheumatology, Veteran Health Service Medical Center, Seoul, South Korea, 3Department of Rheumatology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju-si, Jeju-do, South Korea, La Jolla, CA, South Korea, 4Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, 5Department of Information Medicine, Big Data Research Center, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, South Korea, 6Asan Medical Center, Seoul, South Korea

    Background/Purpose: Myelodysplastic syndrome (MDS) is a hematologic disorder characterized by dysplasia of bone marrow, leading to ineffective hematopoiesis and cytopenia. Despite sporadic reports of associations…
  • Abstract Number: 0453 • ACR Convergence 2023

    Risk of Lung Cancer in Veterans with Rheumatoid Arthritis in Relation to Use of Conventional versus Biologic or Targeted Synthetic DMARDs

    Namrata Singh1, Alexander Peterson2, Aaron Baraff2, K Wysham3, Bryant England4, Joshua Baker5, Nicholas Smith2, Ted R Mikuls6 and Noel Weiss7, 1University of Washington, Bellevue, WA, 2VA Puget Sound Seattle, Seattle, WA, 3VA Puget Sound/University of Washington, Seattle, WA, 4University of Nebraska Medical Center, Omaha, NE, 5University of Pennsylvania, Philadelphia, PA, 6Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, 7University of Washington, Seattle, WA

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased risk of lung cancer compared to the general population. While smoking is a shared risk factor,…
  • Abstract Number: 0700 • ACR Convergence 2023

    A Population-Based Study of Vasculitis Among Farmers and Urban Residents in Alberta

    Elaine Yacyshyn, Simran Gulati, Whitney Hung, Don Voaklander and Allyson Jones, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Systemic vasculitis encompasses a group of autoimmune diseases involving inflammation of blood vessels. Although a rare disease, vasculitis can present with life-threatening symptoms which…
  • Abstract Number: 0983 • ACR Convergence 2023

    Association Between Disease-modifying Anti-rheumatic Drugs and Short-term Outcomes of Dengue: A Population-based, Cohort Study

    I-Feng Lin1, Hsin-Hua Chen2, Theodore Tsai3 and Nicole Huang4, 1National Yang Ming Chiao Tung University, Taipei, Taiwan, 2Taichung Veterans General Hospital, Taichung, Taiwan, 3Takeda Vaccines, Cambridge, MA, 4Master of Public Health Program, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Background/Purpose: Dengue is the leading vectorborne disease globally with half of the global population at risk, including Puerto Rico in the United States. Previously, we…
  • Abstract Number: 1268 • ACR Convergence 2023

    Clinical Characteristics of Patients with Rheumatoid Arthritis (RA) Who Rate Their Global Assessment of Disease Activity Substantially Lower Than Their Physicians (Negative Discordance) Based on a Large RA Database in Japan: A Rare but Important Subgroup

    Tetsuji Sawada1, Susumu Nishiyama2, Shohei Yamashita3, Toshihiro Matsui4 and Shigeto Tohma5, 1Tokyo Medical University Hospital, Shinjuku Tokyo, Japan, 2Kurashiki Medical Center, Kurashiki, Japan, 3Tokyo Medical University Hospital, Shinjuku, Japan, 4NHO Sagamihara National Hospital, Kanagawa, Japan, 5NHO Tokyo National Hospital, Dallas, TX

    Background/Purpose: Discordance between patient global assessment (PGA) and physician global assessment (PhGA) regarding the disease activity of rheumatoid arthritis (RA) can be divided into three…
  • Abstract Number: 1804 • ACR Convergence 2023

    Plant-based Diet Quality and the Risk of Gout: Results from Two Prospective Cohort Studies of US Men and Women

    Sharan Rai1, Frank Hu1, Molin Wang1, Hyon K. Choi2 and Qi Sun1, 1Harvard T.H. Chan School of Public Health, Boston, MA, 2Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: Plant-based diets are growing in popularity due to their health benefits for selected cardiometabolic diseases as well as favorable environmental impact. However, the limited…
  • Abstract Number: 1947 • ACR Convergence 2023

    National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England

    Jennifer Hannah1, Fiona Pearce2, Myron Odingo2, Megan Rutter2, Jeanette Aston3, Jennifer Lai3, Matthew Grainge2, Sean Mcphail3, Peter Lanyon2, Mary Bythell3, James Galloway4 and Patrick Gordon5, 1King's College London, London, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3National Disease Registration Service, Leeds, United Kingdom, 4King's College London, London, United Kingdom, 5NHS, London, United Kingdom

    Background/Purpose: Ethnicity, sex, age & socioeconomic deprivation can all lead to health inequity. Impact of these factors in epidemiology of Idiopathic Inflammatory Myopathies (IIM) has…
  • Abstract Number: 2268 • ACR Convergence 2023

    Mental Illness and Outcomes of COVID-19 in Patients with Systemic Lupus Erythematosus: A Global Multicenter Cohort Study

    Hsin-Hua Chen, Taichung Veterans General Hospital, Taichung, Taiwan

    Background/Purpose: Poor COVID-19 outcomes in patients with systemic lupus erythematosus (SLE) has been found to be associated with glucocorticoid dose, male sex, older age, mycophenolate,…
  • Abstract Number: 2514 • ACR Convergence 2023

    Myositis Triad Subset Is Associated with High Mortality in Immune Checkpoint Inhibitor- Induced Myositis

    Selene Rubino1, Grant Cannon2, Brian Sauer3, Jorge Rojas Jr4, Greg Stoddard1, Gary Kunkel1, Jessica A Walsh5, Bryant England6, Ted R Mikuls7, Joshua Baker8 and Tawnie Braaten1, 1University of Utah, Salt Lake City, UT, 2University of Utah and Salt Lake City VA, Salt Lake City, UT, 3Salt Lake City VA/University of Utah, Salt Lake City, UT, 4Puget Sound VA and University of Utah, Seattle, WA, 5Salt Lake City Veterans Affairs Health and University of Utah Health, Division of Rheumatology, Salt Lake City, UT, 6University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, 8University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Myositis is an infrequent but serious complication associated with immune check point inhibitor (ICI) treatment. Many patients with ICI-induced myositis will develop concurrent myocarditis…
  • Abstract Number: 0138 • ACR Convergence 2023

    Prevalence and Incidence of Sjögren’s Syndrome: A Systematic Literature Review

    Jiyoon Choi1, Kimberly Hofer2, Nishu Gaind2, Mir Sohail Fazeli2, Robert Carroll3, Antoine G Sreih3 and Antonia Christodoulou3, 1Bristol Myers Squibb, Lawrenceville, NJ, 2Evidinno Outcomes Research Inc., Vancouver, BC, Canada, 3Bristol Myers Squibb, Princeton Pike, NJ

    Background/Purpose: Sjögren's syndrome (SjS) is a chronic autoimmune disease that has been historically categorized into primary (manifesting alone; pSjS) or secondary (appearing alongside another underlying…
  • Abstract Number: 0467 • ACR Convergence 2023

    Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals with Autoimmune Rheumatic Diseases and Antiphospholipid Syndrome

    Rashmi Dhital, Rebecca Baer and Christina Chambers, University of California San Diego, La Jolla, CA

    Background/Purpose: Autoimmune rheumatic diseases (ARD) and antiphospholipid syndrome (APS) are autoimmune conditions with increased risks of cardiovascular complications as well as negative pregnancy consequences. We…
  • Abstract Number: 0722 • ACR Convergence 2023

    Acute Cardiovascular Events in Autoimmune Rheumatic Disease Pregnancies

    Rashmi Dhital1, Rebecca Baer2, Monica Guma2, Kenneth Kalunian2, Accelerating Medicines Partnership Program RA SLE Network3 and Christina Chambers2, 1UC San Diego, San Diego, CA, 2University of California San Diego, La Jolla, CA, 3Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Cardiovascular diseases (CVDs) complicate 1-4% of pregnancies. Autoimmune rheumatic diseases (ARDs) are associated with a 1.5 to 3-fold higher CVD risk. Similarly, antiphospholipid syndrome…
  • Abstract Number: 0984 • ACR Convergence 2023

    Factors Associated with 5-year Mortality in Patients with Rheumatoid Arthritis Initiating Their First Biological or Target Synthetic DMARDs: A Nationwide, Population-based Cohort Study of 12,612 Patients

    Hsin-Hua Chen, Taichung Veterans General Hospital, Taichung, Taiwan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease resulting in increased mortality. manifestations. involvement. The National Health Insurance Research Database (NHIRD) in Taiwan…
  • Abstract Number: 1296 • ACR Convergence 2023

    Decline in Incidence of Extraarticular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study

    Bradly Kimbrough1, Cynthia Crowson1, John Davis1, Eric Matteson2 and Elena Myasoedova1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic College of Medicine and Science, Rochester, MN, USA, Rochester, MN

    Background/Purpose: Extraarticular manifestations of rheumatoid arthritis (ExRA) are associated with increased disease burden and mortality. They are also common, affecting about half of patients with…
  • Abstract Number: 1805 • ACR Convergence 2023

    Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake

    Sho Fukui1, Masato Okada2, Tomohiro Shinozaki3, Takahiro Asano2, Takehiro Nakai2, Hiromichi Tamaki2, Mitsumasa Kishimoto4, Hiroshi Hasegawa5, Takeaki Matsuda5, Javier Marrugo1, Sara Tedeschi1 and Daniel Solomon6, 1Brigham and Women's Hospital, Boston, MA, 2St. Luke's International Hospital, Tokyo, Japan, 3Tokyo University of Science, Tokyo, Japan, 4Kyorin University School of Medicine, Yokohoma, Japan, 5Kyorin University, Tokyo, Japan, 6Brigham and Women's Hospital, Newton, MA

    Background/Purpose: Cross-sectional epidemiologic studies support a direct relationship between alcohol intake and serum urate (SU). These observations are parts of the basis for gout recommendations…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology